Current Diabetes Reports最新文献_第10页

Artificial Intelligence Algorithms in Diabetic Retinopathy Screening 糖尿病视网膜病变筛查中的人工智能算法

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2022-04-19 DOI: 10.1007/s11892-022-01467-y

S. Zafar, Heba Mahjoub, N. Mehta, A. Domalpally, R. Channa

引用次数: 4

Young Children with Type 1 Diabetes: Recent Advances in Behavioral Research 幼儿1型糖尿病:行为学研究的最新进展

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2022-04-18 DOI: 10.1007/s11892-022-01465-0

Maureen Monaghan, Breana L. Bryant, Hailey Inverso, Hailey Moore, R. Streisand

引用次数: 9

Loss-of-Control Eating and Cardiometabolic Health in Relation to Overweight and Obesity 与超重和肥胖有关的饮食失控和心脏代谢健康

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2022-04-11 DOI: 10.1007/s11892-022-01466-z

L. Shank, Nasreen A Moursi, M. Tanofsky-Kraff

引用次数: 2

Correction to: Emergency Glucagon: a Focused Review of Psychosocial Experiences of Rescue Drugs for Type 1 Diabetes 纠正:紧急胰高血糖素:1型糖尿病抢救药物的社会心理经验的重点回顾

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2022-04-01 DOI: 10.1007/s11892-022-01463-2

Katherine S Chapman, Allyson S Hughes, Jeoffrey A. Bispham, C. León, Huyen Nguyen, Wendy A. Wolf

引用次数: 0

The Impact of Meal Timing on Risk of Weight Gain and Development of Obesity: a Review of the Current Evidence and Opportunities for Dietary Intervention 进餐时间对体重增加和肥胖发展风险的影响:对当前证据和饮食干预机会的回顾

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2022-04-01 DOI: 10.1007/s11892-022-01457-0

Rochelle Davis, Michelle Rogers, A. Coates, Gloria K. W. Leung, M. Bonham

引用次数: 14

Role of the Autonomic Nervous System in the Hemodynamic Response to Hyperinsulinemia-Implications for Obesity and Insulin Resistance. 自主神经系统在高胰岛素血症血流动力学反应中的作用——对肥胖和胰岛素抵抗的影响。

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2022-04-01 DOI: 10.1007/s11892-022-01456-1

Jacqueline K Limberg, Rogerio N Soares, Jaume Padilla

{"title":"Role of the Autonomic Nervous System in the Hemodynamic Response to Hyperinsulinemia-Implications for Obesity and Insulin Resistance.","authors":"Jacqueline K Limberg, Rogerio N Soares, Jaume Padilla","doi":"10.1007/s11892-022-01456-1","DOIUrl":"https://doi.org/10.1007/s11892-022-01456-1","url":null,"abstract":"Purpose of review: Herein, we summarize recent advances which provide new insights into the role of the autonomic nervous system in the control of blood flow and blood pressure during hyperinsulinemia. We also highlight remaining gaps in knowledge as it pertains to the translation of findings to relevant human chronic conditions such as obesity, insulin resistance, and type 2 diabetes.Recent findings: Our findings in insulin-sensitive adults show that increases in muscle sympathetic nerve activity with hyperinsulinemia do not result in greater sympathetically mediated vasoconstriction in the peripheral circulation. Both an attenuation of α-adrenergic-receptor vasoconstriction and augmented β-adrenergic vasodilation in the setting of high insulin likely explain these findings. In the absence of an increase in sympathetically mediated restraint of peripheral vasodilation during hyperinsulinemia, blood pressure is supported by increases in cardiac output in insulin-sensitive individuals. We highlight a dynamic interplay between central and peripheral mechanisms during hyperinsulinemia to increase sympathetic nervous system activity and maintain blood pressure in insulin-sensitive adults. Whether these results translate to the insulin-resistant condition and implications for long-term cardiovascular regulation warrants further exploration.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"22 4","pages":"169-175"},"PeriodicalIF":4.2,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012695/pdf/nihms-1789745.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9226379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Integrated Behavioral Interventions for Adults with Comorbid Obesity and Depression: a Systematic Review 成人合并肥胖和抑郁的综合行为干预:系统综述

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2022-03-18 DOI: 10.1007/s11892-022-01458-z

N. Lv, E. Kringle, Jun Ma

引用次数: 7

It Is Not Just Fat: Dissecting the Heterogeneity of Adipose Tissue Function 不仅仅是脂肪：脂肪组织功能的异质性剖析

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2022-03-10 DOI: 10.1007/s11892-022-01455-2

Vissarion Efthymiou, M. Patti

引用次数: 2

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus. 诊断和筛查2型糖尿病的生物标志物研究进展

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2022-03-01 Epub Date: 2022-03-10 DOI: 10.1007/s11892-022-01453-4

Margarita Ortiz-Martínez, Mirna González-González, Alexandro J Martagón, Victoria Hlavinka, Richard C Willson, Marco Rito-Palomares

{"title":"Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus.","authors":"Margarita Ortiz-Martínez, Mirna González-González, Alexandro J Martagón, Victoria Hlavinka, Richard C Willson, Marco Rito-Palomares","doi":"10.1007/s11892-022-01453-4","DOIUrl":"10.1007/s11892-022-01453-4","url":null,"abstract":"Purpose of review: Diabetes mellitus is a complex, chronic illness characterized by elevated blood glucose levels that occurs when there is cellular resistance to insulin action, pancreatic β-cells do not produce sufficient insulin, or both. Diabetes prevalence has greatly increased in recent decades; consequently, it is considered one of the fastest-growing public health emergencies globally. Poor blood glucose control can result in long-term micro- and macrovascular complications such as nephropathy, retinopathy, neuropathy, and cardiovascular disease. Individuals with diabetes require continuous medical care, including pharmacological intervention as well as lifestyle and dietary changes.Recent findings: The most common form of diabetes mellitus, type 2 diabetes (T2DM), represents approximately 90% of all cases worldwide. T2DM occurs more often in middle-aged and elderly adults, and its cause is multifactorial. However, its incidence has increased in children and young adults due to obesity, sedentary lifestyle, and inadequate nutrition. This high incidence is also accompanied by an estimated underdiagnosis prevalence of more than 50% worldwide. Implementing successful and cost-effective strategies for systematic screening of diabetes mellitus is imperative to ensure early detection, lowering patients' risk of developing life-threatening disease complications. Therefore, identifying new biomarkers and assay methods for diabetes mellitus to develop robust, non-invasive, painless, highly-sensitive, and precise screening techniques is essential. This review focuses on the recent development of new clinically validated and novel biomarkers as well as the methods for their determination that represent cost-effective alternatives for screening and early diagnosis of T2DM.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"22 1","pages":"95-115"},"PeriodicalIF":5.2,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42274080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Racial Disparities and Cardiometabolic Risk: New Horizons of Intervention and Prevention. 种族差异与心脏代谢风险：干预与预防的新视野》（Racial Disparities and Cardiometabolic Risk: New Horizons of Intervention and Prevention.

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2022-03-01 Epub Date: 2022-02-17 DOI: 10.1007/s11892-022-01451-6

Eftitan Y Akam, Akua A Nuako, Afkera K Daniel, Fatima Cody Stanford

{"title":"Racial Disparities and Cardiometabolic Risk: New Horizons of Intervention and Prevention.","authors":"Eftitan Y Akam, Akua A Nuako, Afkera K Daniel, Fatima Cody Stanford","doi":"10.1007/s11892-022-01451-6","DOIUrl":"10.1007/s11892-022-01451-6","url":null,"abstract":"Purpose of review: Cardiometabolic diseases are a leading cause of morbidity and mortality in the USA and disproportionately impact racial and ethnic minorities. Multiple factors contribute to this disparity including genetic and socioeconomic factors, the latter of which contributes to disparities both through systemic barriers such as healthcare access and by directly impacting metabolism through epigenetics and environment-related alterations in the gut microbiome. This review will discuss advances in medicine that can be used to identify, prognosticate, and treat cardiometabolic diseases, and how these may be used to address existing disparities.Recent findings: There is growing research aimed at identifying novel cardiometabolic disease targets and expanding the use of existing pharmacotherapies based on comorbidities. Advances in metabolomics and genomics can give insight into an individual's unique biochemical profile, providing the means for earlier identification of disease and specific treatment targets. Moreover, developments in telehealth and related medical device technologies can expand access to underserved minority populations and improve control of chronic conditions such as diabetes and hypertension. Precision medicine may be integral to bridging the racial gap in cardiometabolic disease outcomes. Developments in genomics, metabolomics, wearable medical devices, and telehealth can result in personalized treatments for patients that account for the socioeconomic and genetic factors that contribute to poor health outcomes in minorities. As research in this field rapidly progresses, special efforts must be made to ensure inclusion of racial and ethnic minority populations in clinical research and equal access to all treatment modalities.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"22 3","pages":"129-136"},"PeriodicalIF":5.2,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908372/pdf/nihms-1867660.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0